Material Accounting Policies (Details) |
12 Months Ended |
|---|---|
Jan. 31, 2025 | |
| Blife Therapeutics Inc. [Member] | |
| Statement [Line Items] | |
| % of ownership | 100.00% |
| Jurisdiction | Canada |
| BetterLife Pharma US Inc. [Member] | |
| Statement [Line Items] | |
| % of ownership | 100.00% |
| Jurisdiction | U.S.A. |
| MedMelior Inc. [Member] | |
| Statement [Line Items] | |
| % of ownership | 91.00% |
| Jurisdiction | Canada |
| BetterLife Pharma Inc. [Member] | |
| Statement [Line Items] | |
| % of ownership | Parent |
| Jurisdiction | Canada |
| Altum Pharma (Australia) Pty Ltd. [Member] | |
| Statement [Line Items] | |
| % of ownership | 91.00% |
| Jurisdiction | Australia |
| Altum Pharmaceuticals (HK) Limited [Member] | |
| Statement [Line Items] | |
| % of ownership | 91.00% |
| Jurisdiction | Hong Kong |